Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma

Table 3

Discriminatory performance of conventional scores and the nomogram for predicting PHLF grade B-C.

	Training set (n = 383)			Validation set (n = 191)
	AUC	95% CI	value	AUC	95% CI	value
Child–Pugh	0.662	0.580–0.745	<0.001	0.669	0.555–0.783	0.006
MELD	0.595	0.516–0.674	=0.020	0.621	0.499–0.742	0.048
ALBI	0.673	0.597–0.748	<0.001	0.715	0.606–0.825	<0.001
APRI	0.707	0.638–0.777	<0.001	0.604	0.487–0.720	0.089
PALBI	0.731	0.653–0.808	<0.001	0.669	0.558–0.782	0.006
FIB-4	0.758	0.692–0.824	<0.001	0.716	0.623–0.809	<0.001
Nomogram	0.832	0.777–0.886	<0.001	0.803	0.723–0.883	<0.001

Abbreviations: MELD, model for end-stage liver disease; ALBI, albumin-bilirubin; APRI, aspartate aminotransferase to platelet ratio index; PALBI, platelet-albumin-bilirubin; FIB-4, fibrosis-4 index.